Ledger.Open graph →
SEC Form D · filed April 3, 2018

Intellipharmaceutics International Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TORONTO, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kenneth R. Keirstead · Toronto, Ontario, CanadaDirectorIsa Odidi · Toronto, Ontario, CanadaExec · DirectorEldon R. Smith · Toronto, Ontario, CanadaDirectorAmina Odidi · Toronto, Ontario, CanadaExec · DirectorAndrew R. Patient · Toronto, Ontario, CanadaExecBahadur R. Madhani · Toronto, Ontario, CanadaDirectorJames L. Pennington · Brooklyn, NYDirectorCharles Casamento · Brooklyn, NYExec · DirectorBenjamin Black · Seattle, WAExecCraigile J. Brumfield · San Francisco, CAExec · DirectorDaniela Tudor · Seattle, WADirectorTimothy Kerr · Seattle, WADirectorPatrick M. Bohle · Boulder, CODirectorStewart B. Couper · Boulder, CODirectorKeith Bank · Chicago, ILExecScott Paseltiner · Chicago, ILExec · DirectorStefan Birrer · Chicago, ILExec · DirectorJose E. De Castro · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗